Kemin takes gut health management to a new level with the development of CLOSTAT. Following extensive research, CLOSTAT is the first health product to be categorized as an active microbial. The micro-organism selected for use in CLOSTAT was isolated from the gut of a healthy chicken surviving a necrotic enteritis outbreak. Numerous research and field- trials carried out worldwide have demonstrated the efficacy of CLOSTAT.

A disrupted gastrointestinal tract will quickly lead to the proliferation of Clostridium perfringens, the causative organism for necrotic enteritis. It is a widespread problem in the poultry industry and is known to seriously damage profits. CLOSTAT is the ultimate solution for decreasing production losses due to necrotic enteritis.